US 11372002
Assays for determining plasma kallikrein system biomarkers
granted A61KA61K2039/505A61P
Quick answer
US patent 11372002 (Assays for determining plasma kallikrein system biomarkers) held by Takeda Pharmaceutical Company Limited expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61P, A61P29/00, A61P43/00